Michelle Elliott

24PUBLICATIONS
65CO-AUTHORS
Haematological tumoursGene and molecular therapyFoetal development and medicineCancer therapy (excl. chemotherapy and radiation therapy)Cellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 18, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.

|Dec 13, 2024
Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.

Naseema Gangat, Azeem Elbeih, Nour Ghosoun

|Jun 13, 2024
Aspirin therapy is associated with a lower risk of pregnancy loss in both JAK2- and CALR-mutated essential thrombocythemia-A Mayo Clinic study of 200 pregnancies.

Naseema Gangat, Amritpal Singh, Rimal Ilyas

|Dec 15, 2023
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.

Omer Karrar, Maymona Abdelmagid, Masooma Rana

|Sep 09, 2023
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.

Animesh Pardanani, Ayalew Tefferi, Aref Al-Kali

|Jun 15, 2022
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.

Ayalew Tefferi, Naseema Gangat, Aref Al-Kali

Pageof 4

Frequent Collaborators

21 joint publications

Ayalew Tefferi

17 joint publications

Kebede H Begna

16 joint publications

Naseema Gangat

14 joint publications

Animesh Pardanani